Company: ECIA
Filing Date: 2025-07-14
Form Type: DEF 14A
Source: 0001079973-25-001145
Chunk: 9

Company: ENCISION INC
Filing Date: 2025-07-14
Form: DEF 14A
Chunk 9
---
ercised options (#) 
 exercisable                                      |        |     | Number                                           
 of securities underlying unexercised options (#) 
 unexercisable                                    |        |     | Number                                                
 of securities underlying unexercised equity units (#) 
 exercisable                                           |   |     | Number                                                
 of securities underlying unexercised equity units (#) 
 unexercisable                                         |   |
| Robert H. Fries       |     |                                                  | 23,611 |     |                                                  | 61,389 |     |                                                       | 0 |     |                                                       | 0 |
| Vern D. Kornelsen     |     |                                                  | 63,056 |     |                                                  | 21,944 |     |                                                       | 0 |     |                                                       | 0 |
| Patrick W. Pace, M.D. |     |                                                  | 41,946 |     |                                                  | 43,054 |     |                                                       | 0 |     |                                                       | 0 |

Nominating Committee; Nominations Process

The members of our nominating
committee are Robert H. Fries, Vern D. Kornelsen and Patrick W. Pace, M.D. Our nominating committee recommends to our board of directors
nominees for election to the board. Our nominating committee will consider recommendations for director nominees by shareholders if the
names of those nominees and the other required information are properly submitted in writing to our corporate secretary in the manner
described for shareholder nominations above under the heading “Shareholder Proposals and Director Nominations.” A director
nominee must have a strong professional or other background, a reputation for integrity and responsibility and experience relevant to
our business and operations. A director nominee must be able to commit appropriate time to prepare for, attend and participate in all
meetings of our board of directors and its committees, as applicable, and the annual meeting of shareholders and must not have any conflicts
of interest with our business and operations. Our nominating committee will also require some director nominees to be independent as defined
under the NYSE listing standards. All director nominees, whether submitted by a shareholder or our nominating committee, will be evaluated
in the same manner. All current members of the nominating committee are independent for purposes of the NYSE listing standards.

The nominating committee does
not have an express policy with regard to the consideration of any director candidates recommended by our shareholders because the nominating
committee believes that it can adequately evaluate any such nominees